News | August 08, 2025
IOL Chemicals post Q1 FY26 consolidated profit at Rs. 33.93 Cr
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
The submission is supported by positive results from the Phase 3 AMPLIFY trial
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Subscribe To Our Newsletter & Stay Updated
